Is Baudax Bio Inc (BXRX) Stock Worth a Buy Thursday?
Thursday, September 28, 2023 09:40 AM | InvestorsObserver Analysts
Mentioned in this article
Baudax Bio Inc (BXRX) stock has fallen -93.15% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives BXRX stock a score of 3 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 3. BXRX's rank also includes a long-term technical score of 6.
BXRX has an Overall Score of 3. Find out what this means to you and get the rest of the rankings on BXRX!
Baudax Bio Inc (BXRX) stock is higher by 119.57% while the S&P 500 has fallen -0.06% as of 9:37 AM on Thursday, Sep 28. BXRX has risen $0.36 from the previous closing price of $0.30 on volume of 23,352,793 shares. Over the past year the S&P 500 has gained 14.87% while BXRX has fallen -93.15%. BXRX lost -$107.62 per share in the over the last 12 months.
Click Here to get the full Stock Report for Baudax Bio Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter